Ignite Creation Date:
2024-05-06 @ 8:26 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06388655
Status:
COMPLETED
Last Update Posted:
2024-04-29
First Post:
2024-04-15
Brief Title:
The Effect of the Mobile EEG-Neurofeedback in Healthy Child and Adolescent
Sponsor:
Daegu Catholic University Medical Center
Organization:
Daegu Catholic University Medical Center
Study Overview
Official Title:
The Effect of the Mobile EEG-Neurofeedback in Healthy Child and Adolescent Participants a Randomized Sham-control Study
Status:
COMPLETED
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objective of this study was to ascertain the therapeutic impact of mobile neurofeedback MNF in neurotypical children when compared to sham MNF Clinical assessments were conducted both before and after the MNF intervention and the effectiveness of the intervention was to be validated through these evaluations
Detailed Description:
Neurotypical children aged 10-15 participated in the study All subjects were assessed using the Kiddie Schedule for Affective Disorders and Schizophrenia Present and Lifetime Version Korean Version K-SADS-PL-K and confirmed to have no psychiatric symptoms The participants were randomly assigned to the MNF active N31 or sham control N30 groups The MNF program was administered using a mobile app equipped with a headset with a 2-channel EEG sensor for 30 minday 3 daysweek for 3 months All participants and their parents completed self-report scales and participants complete neurocognitive function assessments including the continuous performance test Stroop childrens color trails test-1 and 2 and intelligence test at baseline and after the 3-month MNF program
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None